217 related articles for article (PubMed ID: 15778364)
21. The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest.
Hornung M; Lindemann D; Kraus C; Peters A; Berberich I
Eur J Immunol; 1998 Nov; 28(11):3812-23. PubMed ID: 9842924
[TBL] [Abstract][Full Text] [Related]
22. Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.
Zhang W; Shi Q; Xu X; Chen H; Lin W; Zhang F; Zeng X; Zhang X; Ba D; He W
PLoS One; 2012; 7(8):e41644. PubMed ID: 22952582
[TBL] [Abstract][Full Text] [Related]
23. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.
Ahmed-Choudhury J; Russell CL; Randhawa S; Young LS; Adams DH; Afford SC
Mol Biol Cell; 2003 Apr; 14(4):1334-45. PubMed ID: 12686591
[TBL] [Abstract][Full Text] [Related]
24. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
26. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
28. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
Schwabe RF; Schnabl B; Kweon YO; Brenner DA
J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
[TBL] [Abstract][Full Text] [Related]
29. Receptor-specific induction of NF-kappaB components in primary B cells.
Francis DA; Sen R; Rice N; Rothstein TL
Int Immunol; 1998 Mar; 10(3):285-93. PubMed ID: 9576616
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.
Davies CC; Bem D; Young LS; Eliopoulos AG
Cell Signal; 2005 Jun; 17(6):729-38. PubMed ID: 15722197
[TBL] [Abstract][Full Text] [Related]
31. An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cells.
Schlezinger JJ; Emberley JK; Bissonnette SL; Sherr DH
Toxicol Sci; 2007 Jul; 98(1):125-36. PubMed ID: 17400580
[TBL] [Abstract][Full Text] [Related]
32. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
[TBL] [Abstract][Full Text] [Related]
33. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB.
O'Sullivan BJ; Thomas R
J Immunol; 2002 Jun; 168(11):5491-8. PubMed ID: 12023343
[TBL] [Abstract][Full Text] [Related]
35. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
36. Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand.
Wen X; Li Y; Liu Y
J Biol Chem; 2010 Sep; 285(39):29981-8. PubMed ID: 20663893
[TBL] [Abstract][Full Text] [Related]
37. Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2.
Schlezinger JJ; Howard GJ; Hurst CH; Emberley JK; Waxman DJ; Webster T; Sherr DH
J Immunol; 2004 Sep; 173(5):3165-77. PubMed ID: 15322177
[TBL] [Abstract][Full Text] [Related]
38. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway.
Ray DM; Morse KM; Hilchey SP; Garcia TM; Felgar RE; Maggirwar SB; Phipps RP; Bernstein SH
Exp Hematol; 2006 Sep; 34(9):1202-11. PubMed ID: 16939813
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.
Scirpo R; Fiorotto R; Villani A; Amenduni M; Spirli C; Strazzabosco M
Hepatology; 2015 Nov; 62(5):1551-62. PubMed ID: 26199136
[TBL] [Abstract][Full Text] [Related]
40. PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.
Lim HA; Lee EK; Kim JM; Park MH; Kim DH; Choi YJ; Ha YM; Yoon JH; Choi JS; Yu BP; Chung HY
Biogerontology; 2012 Apr; 13(2):133-45. PubMed ID: 22033706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
